Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02299206 · ClinicalTrials.gov registry record · NA
CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02299206: Clinical Trial NA study, sponsored by Northwestern University.
NCT02299206 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02299206, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This is a single-center, 1:1 randomized, double-blind, parallel-group, non-inferiority controlled trial to demonstrate non-inferiority of CeraVe Baby Diaper Rash Cream compared to Desitin Maximum Strength Original Paste when administered to children with diaper dermatitis who are between 3 months to 18 months of age. Parents/caregivers of subjects in both groups will administer the product with each diaper change throughout the course of the study period. Product can be applied liberally as needed. Diapers and skin cleansing interventions will stay constant throughout the treatment period. Subjects will be assessed by the study doctor, parent/caregiver will be asked about any adverse effects. Parent/caregivers will also be asked to complete a daily diary that asks about changes in their baby's diaper dermatitis, a Visual Analogue Scale severity assessment of their baby's diaper dermatitis, and observations related to product use and the baby's comfort level. Parents/caregivers will also be given a questionnaire rating the use of the study products.
Primary Outcome
For each visit the study doctor will assess the diaper dermatitis severity with a Diaper Dermatitis Severity Score tool. In Addition, location of clinically apparent involved area will be shaded by hand onto diagram by the research personnel. Scores will be compared.
Interventions
- DRUG CeraVe Baby Diaper Rash Cream
- DRUG Desitin Maximum Strength Original Paste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-07 |
| Phase | NA |
Why NCT02299206 stopped before completion
NCT02299206 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which CeraVe Baby Diaper Rash Cream is the first listed.
NCT02299206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02299206 about?
NCT02299206 is a clinical study titled "CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants". This is a single-center, 1:1 randomized, double-blind, parallel-group, non-inferiority controlled trial to demonstrate non-inferiority of CeraVe Baby Diaper Rash Cream compared to Desitin Maximum Strength Original Paste when administered to children with diaper dermatitis who are between 3 months to...
What is the current status of trial NCT02299206?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-12. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02299206?
The interventions under investigation include: CeraVe Baby Diaper Rash Cream (DRUG), Desitin Maximum Strength Original Paste (DRUG).
Who is sponsoring clinical trial NCT02299206?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02299206's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia